Novel Role for Caspase-Activated DNase in the Regulation of Pathological Cardiac Hypertrophy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  HYPERTENSION

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.114.04806PMID 25646292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noninvasive Positive Pressure Ventilation in Chronic Heart Failure

  2016cited by this paper
• Loss of Caspase‐Activated DNase Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice

  2016cited by this paper
• Dickkopf-3 attenuates pressure overload-induced cardiac remodelling.

  2014cited by this paper
• IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling

  2014cited by this paper
• Signal Regulatory Protein-&agr; Protects Against Cardiac Hypertrophy Via the Disruption of Toll-Like Receptor 4 Signaling

  2014cited by this paper
• Interferon Regulatory Factor 9 Protects Against Cardiac Hypertrophy by Targeting Myocardin

  2014cited by this paper
• Exogenous high‐mobility group box 1 protein prevents postinfarction adverse myocardial remodeling through TGF‐β/Smad signaling pathway

  2013cited by this paper
• Role of Interferon Regulatory Factor 4 in the Regulation of Pathological Cardiac Hypertrophy

  2013cited by this paper
• Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway

  2013cited by this paper
• Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy

  2013cited by this paper
• Mitochondrial DNA That Escapes from Autophagy Causes Inflammation and Heart Failure

  2012cited by this paper
• Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction

  2011cited by this paper
• Caspase 3/caspase-activated DNase promote cell differentiation by inducing DNA strand breaks

  2010cited by this paper
• Intracellular or extracellular heat shock protein 70 differentially regulates cardiac remodelling in pressure overload mice.

  2010cited by this paper
• Cellular FLICE-Inhibitory Protein Protects Against Cardiac Remodeling Induced by Angiotensin II in Mice

  2010cited by this paper
• Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

  2010cited by this paper
• Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload

  2010cited by this paper
• With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure.

  2009cited by this paper
• Increased skin carcinogenesis in caspase-activated DNase knockout mice.

  2009cited by this paper
• Gelsolin Regulates Cardiac Remodeling After Myocardial Infarction Through DNase I–Mediated Apoptosis

  2009cited by this paper
• Activation of Histone Deacetylase 2 by Inducible Heat Shock Protein 70 in Cardiac Hypertrophy

  2008cited by this paper
• Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy.

  2008cited by this paper
• TGFβ, cardiac fibroblasts, and the fibrotic response

  2007cited by this paper
• The Fuzzy Logic of Physiological Cardiac Hypertrophy

  2007cited by this paper
• ECM remodeling in hypertensive heart disease.

  2007cited by this paper
• TGFbeta, cardiac fibroblasts, and the fibrotic response.

  2007cited by this paper
• Targeted Cardiac Overexpression of A20 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction

  2007cited by this paper
• The p38 MAPK signaling pathway: a major regulator of skeletal muscle development.

  2006cited by this paper
• Regulation of cardiac hypertrophy by intracellular signalling pathways

  2006cited by this paper
• A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy

  2006cited by this paper
• Myocyte apoptosis in heart failure.

  2005cited by this paper
• Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.

  2004cited by this paper
• Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation

  2003cited by this paper
• Mutually regulated expression of caspase-activated DNase and its inhibitor for apoptotic DNA fragmentation

  2003cited by this paper
• Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress.

  2002cited by this paper
• Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.

  2002cited by this paper
• Determinants of the Nuclear Localization of the Heterodimeric DNA Fragmentation Factor (Icad/Cad)

  2000cited by this paper
• Characterization of the Rat DNA Fragmentation Factor 35/Inhibitor of Caspase-activated DNase (Short Form)

  2000cited by this paper
• Inhibition of apoptosis-associated DNA fragmentation activity in nonapoptotic cells: the role of DNA fragmentation factor-45 (DFF45/ICAD).

  1998cited by this paper
• The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis.

  1998cited by this paper
• Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

  1998cited by this paper
• ICAD/DFF regulator of apoptotic nuclease is nuclear.

  1998cited by this paper
• CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45.

  1998cited by this paper
• Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45.

  1998cited by this paper
• A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

  1998cited by this paper
• DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.

  1997cited by this paper
• Interferon regulatory factors: growth control and histone gene regulation – it’s not just interferon anymore

  1997cited by this paper

• Freeze-dried herbal Kaempferia galanga supplementation effectively modulates hyperglycemia-induced oxidative stress and apoptosis in diabetic BALB/c mice

  2025cites this paper
• Fas Apoptosis Inhibitory Molecule 2 Inhibits Pathological Cardiac Hypertrophy by Regulating the MAPK Signaling Pathway

  2024cites this paper
• Knock-down of PGM1 inhibits cell viability, glycolysis, and oxidative phosphorylation in glioma under low glucose condition via the Myc signaling pathway.

  2023cites this paper
• PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis

  2022cites this paper
• Inhibition of HIPK2 protects stress-induced pathological cardiac remodeling

  2022cites this paper
• The Role of PKC-MAPK Signalling Pathways in the Development of Hyperglycemia-Induced Cardiovascular Complications

  2022cites this paper
• ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

  2022cites this paper
• Salidroside protects cardiac function in mice with diabetic cardiomyopathy via activation of mitochondrial biogenesis and SIRT3

  2021cites this paper
• Lysosomal-Associated Protein Transmembrane 5 Functions as a Novel Negative Regulator of Pathological Cardiac Hypertrophy

  2021cites this paper
• Apoptotic DNase network: Mutual induction and cooperation among apoptotic endonucleases

  2021cites this paper
• NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin

  2021cites this paper
• Heat Shock Protein 22 Attenuates Doxorubicin-Induced Cardiotoxicity via Regulating Inflammation and Apoptosis

  2020cites this paper
• STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy

  2020cites this paper
• Protective effects of medicinal plant against diabetes induced cardiac disorder: A review.

  2020cites this paper
• Protective Effect of miR-204 on Doxorubicin-Induced Cardiomyocyte Injury via HMGB1

  2020cites this paper
• Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy

  2019cites this paper
• Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate.

  2019cites this paper
• C1QTNF1 attenuates angiotensin II‐induced cardiac hypertrophy via activation of the AMPKa pathway

  2018cites this paper
• Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway

  2018cites this paper
• LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR‐34a in diabetic cardiomyopathy

  2018cites this paper
• NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression

  2018cites this paper
• Circulating Long Noncoding RNA HOTAIR is an Essential Mediator of Acute Myocardial Infarction

  2017cites this paper
• Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin Ⅱ-Induced hypertrophy.

  2017cites this paper
• Isorhamnetin protects against cardiac hypertrophy through blocking PI3K–AKT pathway

  2017cites this paper
• Heart failure research in China: current status and future direction

  2016cites this paper
• Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells

  2016cites this paper
• Shensongyangxin protects cardiomyocytes against LPS-induced injury through the NFκB pathway

  2016cites this paper
• Loss of Caspase‐Activated DNase Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice

  2016cites this paper
• Noninvasive Positive Pressure Ventilation in Chronic Heart Failure

  2016cites this paper
• Growth Arrest–Specific 6 Exacerbates Pressure Overload–Induced Cardiac Hypertrophy

  2016cites this paper